Resolution of inflammation by N-arachidonoylglycine

Journal of Cellular Biochemistry

Volumn 112, Issue 11, 2011, Pages 3227-3233

  Burstein, Sumner H ^a   McQuain, Catherine A ^a   Ross, Alonzo H ^a   Salmonsen, Rebecca A ^a   Zurier, Robert E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

ANTI INFLAMMATORY EICOSANOIDS; CELL DEATH; GPR18; INFLAMMATION; N ARACHIDONOYLGLYCINE; qPCR

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR GPR18; ICOSANOID; LIPOXIN A; N ARACHIDONOYLGLYCIN; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL SURVIVAL; CHRONIC INFLAMMATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; DNA PRIMERS; GLYCINE; HUMANS; INFLAMMATION; MICE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 80055011828     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23245     Document Type: Article

References (23)

1. Bannenberg G, Serhan CN,. 2010. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim Biophys Acta 1801: 1260-1273.
2. Barbara G, Alloui A, Nargeot J, Lory P, Eschalier A, Bourinet E, Chemin J,. 2009. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J Neurosci 29: 13106-13114.
3. Bradshaw HB, Rimmerman N, Hu SS, Benton VM, Stuart JM, Masuda K, Cravatt BF, O'Dell DK, Walker JM,. 2009. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways. BMC Biochem 10: 14.
4. Burstein S,. 2008. The elmiric acids: Biologically active anandamide analogs. Neuropharmacology 55: 1259-1264.
5. Burstein SMA, Pearson W, Rooney T, Yagen B, Zipkin R, Zurier A,. 1997. Studies with analogs of anandamide and indomethacin. Symposium on Cannabinoids. International Cannabinoid Research Society, Burlington, VT, pp 31.
6. Burstein SH, Adams JK, Bradshaw HB, Fraioli C, Rossetti RG, Salmonsen RA, Shaw JW, Walker JM, Zipkin RE, Zurier RB,. 2007. Potential anti-inflammatory actions of the elmiric (lipoamino) acids. Bioorg Med Chem 15: 3345-3355. (Pubitemid 46529271)
7. Burstein SH, Zurier RB,. 2009. Cannabinoids, endocannabinoids, and related analogs in inflammation. AAPS J 11: 109-119.
8. Cascio M, Minassi A, Ligresti A, Appendino G, Burstein S, Di Marzo V,. 2004. A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 314: 192-196. (Pubitemid 38058388)
9. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA,. 1999. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5: 698-701. (Pubitemid 29289435)
10. Herlong JL, Scott TR,. 2006. Positioning prostanoids of the D and J series in the immunopathogenic scheme. Immunol Lett 102: 121-131. (Pubitemid 43053081)
11. Huang SM, Bisogno T, Petros TJ, Chang SY, Zavitsanos PA, Zipkin RE, Sivakumar R, Coop A, Maeda DY, De Petrocellis L, Burstein S, Di Marzo V, Walker JM,. 2001. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem 276: 42639-42644.
12. Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K, Yasukawa M,. 2006. Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun 347: 827-832. (Pubitemid 44109679)
13. McHugh D, Hu SS, Rimmerman N, Juknat A, Vogel Z, Walker JM, Bradshaw HB,. 2010. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci 11: 44.
14. Parmar N, Ho WS,. 2010. N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels. Br J Pharmacol 160: 594-603.
15. Pertwee RG,. 1972. The ring test: A quantitative method for assessing the 'cataleptic' effect of cannabis in mice. Br J Pharmacol 46: 753-763.
16. Pestonjamasp VK, Burstein SH,. 1998. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim Biophys Acta 1394: 249-260. (Pubitemid 28495659)
17. Ross HR, Gilmore AJ, Connor M,. 2009. Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine. Br J Pharmacol 156: 740-750.
18. Ryan GB, Majno G,. 1977. Acute inflammation. A review Am J Pathol 86: 183-276.
19. Samuelsson B,. 1991. Arachidonic acid metabolism: Role in inflammation. Z Rheumatol 50 (Suppl 1): 3-6.
20. Serhan CN,. 2010. Novel lipid mediators and resolution mechanisms in acute inflammation: To resolve or not ? Am J Pathol 177: 1576-1591.
21. Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R,. 1997. Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J Med Chem 40: 659-667. (Pubitemid 27102571)
22. Stables MJ, Gilroy DW,. 2010. Old and new generation lipid mediators in acute inflammation and resolution. Prog Lipid Res 50: 35-51.
23. Vuong LA, Mitchell VA, Vaughan CW,. 2008. Actions of N-arachidonyl- glycine in a rat neuropathic pain model. Neuropharmacology 54: 189-193.